Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2025 16:05 ET | Source: MannKind

MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that its third quarter 2025 financial results will be released...
October 13, 2025 08:05 ET | Source: MannKind

MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes

MannKind Announces U.S. FDA Accepts for Review its sBLA for Inhaled Insulin in Children and Adolescents Aged 4-17
October 07, 2025 09:00 ET | Source: MannKind

MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care

MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care
September 29, 2025 06:05 ET | Source: MannKind

MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer

MannKind appoints Dr. Ajay Ahuja as EVP and Chief Medical Officer
August 27, 2025 16:05 ET | Source: MannKind

MannKind to Present at Upcoming Investor Conferences

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative...
August 27, 2025 08:05 ET | Source: MannKind

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
August 25, 2025 07:30 ET | Source: MannKind

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
August 06, 2025 07:10 ET | Source: MannKind

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
August 06, 2025 07:05 ET | Source: MannKind

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MANNKIND CORPORATION REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
July 30, 2025 16:05 ET | Source: MannKind

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025